Protosappanin A


CAS No. : 102036-28-2

(Synonyms: PTA)

102036-28-2
Price and Availability of CAS No. : 102036-28-2
Size Price Stock
5mg $280 In-stock
10mg $450 In-stock
25mg $742 In-stock
50mg $982 In-stock
100 mg Get quote
200 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-113573
M.Wt: 272.25
Formula: C15H12O5
Purity: >98 %
Solubility: DMSO : 125 mg/mL (ultrasonic)
Introduction of 102036-28-2 :

Protosappanin A (PTA), an immunosuppressive ingredient and major biphenyl compound isolated from Caesalpinia sappan L, suppresses JAK2/STAT3-dependent inflammation pathway through down-regulating the phosphorylation of JAK2 and STAT3[1]. IC50 & Target:JAK2, STAT3[1]. In Vitro: Protosappanin A (PTA: 12.5, 25, 50 μM, 24 hours) significantly inhibits the production of TNF-α and IL-1β in LPS-activated BV2 microglia. And the mRNA expressions of IL-6, IL-1β, and MCP-1 are reduced by PTA in a dose-dependent manner in BV2 microglial cell line[1].
Protosappanin A (PTA: 12.5, 25, 50 μM, 24 hours) suppresses JAK2/STAT3-dependent inflammation pathway through down-regulating the phosphorylation of JAK2 and STAT3, as well as STAT3 nuclear translocation against LPS treatment[1].
Protosappanin A (PTA: 12.5, 25, 50 μM, 24 hours) shows obvious effect on disturbing the interaction of transmembrane protein CD14 with Toll-like receptor-4, resulting in the inhibition of NF-κB-dependent oxidative and nitrative stress in LPS-induced BV2 microglia[2].

Your information is safe with us.